A naukri.com initiative
Bioengineer
7d
24
Image Credit: Bioengineer
Characterizing 2016-2019 A(H1N1)pdm09 Influenza Viruses
- A(H1N1)pdm09 influenza viruses isolated from 2016 to 2019 were comprehensively characterized in a study by Muawan, Takada, and Yoshimoto, shedding light on evolutionary and antigenic dynamics critical for global public health.
- The study delves into genetic, phenotypic, and immunological properties of the recent A(H1N1)pdm09 isolates, highlighting viral adaptations that could impact vaccine effectiveness and pandemic readiness.
- Genetic variability in hemagglutinin and neuraminidase glycoproteins was analyzed, revealing mutations affecting antigenicity and potential resistance to neuraminidase inhibitors.
- The study detected amino acid substitutions in antigenic sites that moderately affected antibody binding, indicating ongoing antigenic drift within circulating strains.
- Serological assays showed heterogeneity in antigenic profiles of isolates, with some strains displaying reduced sensitivity to prior vaccine strains, suggesting mismatches in vaccine selection.
- In vitro replication studies revealed recent isolates maintaining robust replicative capacity despite mutations, crucial for sustained transmission in human populations.
- Phylogenetic analyses mapped lineage diversification and global spread of A(H1N1)pdm09 variants, indicating regional influences on viral evolution.
- The study highlights challenges for influenza vaccine developers in identifying antigenic variants and cautions about potential drug-resistant A(H1N1)pdm09 variants.
- Host immune pressure was identified as a major factor driving viral diversification, with implications for designing more effective influenza vaccines.
- The research also explored mutations outside main antigenic sites to understand viral replication and immune evasion strategies, informing potential therapeutic development.
Read Full Article
1 Like
For uninterrupted reading, download the app